{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:02:23Z","timestamp":1785542543477,"version":"3.56.0"},"reference-count":46,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.1536\/ihj.24-055","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T22:11:57Z","timestamp":1720822317000},"page":"593-600","source":"Crossref","is-referenced-by-count":4,"title":["Iron Deficiency in Pulmonary Hypertension"],"prefix":"10.1536","volume":"65","author":[{"given":"Arif","family":"Albulushi","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Nebraska Medical Center"},{"name":"Division of Adult Cardiology, National Heart Center, Royal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Kashoub","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sultan Qaboos University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al-Saidi","sequence":"additional","affiliation":[{"name":"Division of Adult Cardiology, National Heart Center, Royal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Al-Farhan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sultan Qaboos University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cassady SJ, Ramani GV. Right heart failure in pulmonary hypertension. Cardiol Clin 2020; 38: 243-55.","DOI":"10.1016\/j.ccl.2020.02.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sysol JR, Machado RF. Classification and pathophysiology of pulmonary hypertension. Cont Cardiol Educ 2018; 4: 2-12.","DOI":"10.1002\/cce2.71"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chang KY, Duval S, Badesch DB, <i>et al<\/i>. Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry. J Am Heart Assoc 2022; 11: e024969.","DOI":"10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A1181"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. S Sonnweber T, Pizzini A, Tancevski I, L\u00f6ffler-Ragg J, Weiss G. Anaemia, iron homeostasis and pulmonary hypertension: a review. Intern Emerg Med 2020; 15: 573-85.","DOI":"10.1007\/s11739-020-02288-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gupta DCP. Role of iron (Fe) in body. IOSR J Appl Chem 2014; 7: 38-46.","DOI":"10.9790\/5736-071123846"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Oexle H, Gnaiger E, Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta 1999; 1413: 99-107.","DOI":"10.1016\/S0005-2728(99)00088-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rhodes CJ, Wharton J, Howard L, Gibbs JS, Vonk-Noordegraaf A, Wilkins MR. Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur Respir J 2011; 38: 1453-60.","DOI":"10.1183\/09031936.00037711"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yu X, Luo Q, Liu Z, <i>et al<\/i>. Prevalence of iron deficiency in different subtypes of pulmonary hypertension. Heart Lung 2018; 47: 308-13.","DOI":"10.1016\/j.hrtlng.2018.05.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rhodes CJ, Howard LS, Busbridge M, <i>et al<\/i>. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol 2011; 58: 300-9.","DOI":"10.1016\/j.jacc.2011.02.057"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nanavaty D, Sanghvi A, Patel N, <i>et al<\/i>. Association between iron deficiency anemia (IDA) and venous thromboembolic diseases (VTE). Arterioscler Thromb Vasc Biol 2023; 43: 581-96.","DOI":"10.1161\/atvb.43.suppl_1.581"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Musallam KM, Taher AT. Iron deficiency beyond erythropoiesis: should we be concerned? Curr Med Res Opin 2018; 34: 81-93.","DOI":"10.1080\/03007995.2017.1394833"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Xanthouli P, Theobald V, Benjamin N, <i>et al<\/i>. Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension. Respir Res 2021; 22: 288.","DOI":"10.1186\/s12931-021-01884-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Theobald V, Gr\u00fcnig E, Benjamin N, <i>et al<\/i>. Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients? Pulm Circ 2023; 13: e12242.","DOI":"10.1002\/pul2.12242"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Howard LSGE, He J, Watson GMJ, <i>et al<\/i>. Supplementation with iron in pulmonary arterial hypertension: two randomized crossover trials. Ann Am Thorac Soc 2021; 18: 981-8.","DOI":"10.1513\/AnnalsATS.202009-1131OC"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ghio S, Fortuni F, Capettini AC, <i>et al<\/i>. Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementation. Acta Cardiol 2021; 76: 162-7.","DOI":"10.1080\/00015385.2019.1694760"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Robinson JC, Graham BB, Rouault TC, Tuder RM. The crossroads of iron with hypoxia and cellular metabolism: implications in the pathobiology of pulmonary hypertension. Am J Respir Cell Mol Biol 2014; 51: 721-9.","DOI":"10.1165\/rcmb.2014-0021TR"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kobayashi M, Suhara T, Baba Y, <i>et al<\/i>. Pathological roles of iron in cardiovascular disease. Curr Drug Targets 2018; 19: 1068-76.","DOI":"10.2174\/1389450119666180605112235"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sonnweber T, Nairz M, Theurl I, <i>et al<\/i>. The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension. PLoS ONE 2018; 13: e0203396.","DOI":"10.1371\/journal.pone.0203396"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Malenfant S, Potus F, Mainguy V, <i>et al<\/i>. Impaired skeletal muscle oxygenation and exercise tolerance in pulmonary hypertension. Med Sci Sports Exerc 2015; 47: 2273-82.","DOI":"10.1249\/MSS.0000000000000696"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Weaver CM, Rajaram S. Exercise and iron status. J Nutr 1992; 122: 782-7.","DOI":"10.1093\/jn\/122.suppl_3.782"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ruiter G, Manders E, Happ\u00e9 CM, <i>et al<\/i>. Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm Circ 2015; 5: 466-72.","DOI":"10.1086\/682217"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl 1999; 69: S61-6.","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, <i>et al<\/i>. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 2013; 29: 291-303.","DOI":"10.1185\/03007995.2012.761599"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Schaefer B, Meindl E, Wagner S, Tilg H, Zoller H. Intravenous iron supplementation therapy. Mol Aspects Med 2020; 75: 100862.","DOI":"10.1016\/j.mam.2020.100862"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Smith TG, Talbot NP, Privat C, <i>et al<\/i>. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 2009; 302: 1444-50.","DOI":"10.1001\/jama.2009.1404"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Olsson KM, Fuge J, Brod T, <i>et al<\/i>. Oral iron supplementation with ferric maltol in patients with pulmonary hypertension. Eur Respir J 2020; 56.","DOI":"10.1183\/13993003.00616-2020"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tatah J, Pritzker MR, Thenappan T, Prins KW. Abstract 14287: iron deficiency is associated with more severe pulmonary vascular disease in pulmonary hypertension due to chronic lung disease. Circulation 2020; 142: A14287.","DOI":"10.1161\/circ.142.suppl_3.14287"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ruiter G, Lankhorst S, Boonstra A, <i>et al<\/i>. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 2011; 37: 1386-91.","DOI":"10.1183\/09031936.00100510"},{"key":"29","unstructured":"29. CELL RB. Intrinsic hemolytic anemias comprise a large group of disorders in which defects in the red blood cells (RBCs) occur. <i>Hematology-E-Book: Clinical Principles and Applications<\/i>. 2013 Dec 27: 314."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ramakrishnan L, Pedersen SL, Toe QK, Quinlan GJ, Wort SJ. Pulmonary arterial hypertension: iron matters. Front Physiol 2018; 9: 641.","DOI":"10.3389\/fphys.2018.00641"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Udipi S, Ghugre P, Gokhale C. Iron, oxidative stress and health. Oxidative Stress-Molecular Mechanisms and Biological Effects. Lushchak V, ed. <i>Int J Toxicol Pharmacol Res<\/i>. 2012: 73-108.","DOI":"10.5772\/34975"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kurakula K, Smolders VFED, Tura-Ceide O, Jukema JW, Quax PHA, Goumans MJ. Endothelial dysfunction in pulmonary hypertension: cause or consequence? Biomedicines 2021; 9: 57.","DOI":"10.3390\/biomedicines9010057"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Cornelissen A, Guo L, Sakamoto A, Virmani R, Finn AV. New insights into the role of iron in inflammation and atherosclerosis. EBioMedicine 2019; 47: 598-606.","DOI":"10.1016\/j.ebiom.2019.08.014"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lakhal-Littleton S. Iron deficiency as a therapeutic target in cardiovascular disease. Pharmaceuticals (Basel) 2019; 12: 125.","DOI":"10.3390\/ph12030125"},{"key":"35","unstructured":"35. Adeyemi OS, Akanji MA. Iron and nitric oxide play key roles in the development of cardiovascular disorder. J Toxicol Environ Health Sci 2011; 3: 249-53."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yousaf M, Ilahi M, Bibi A, <i>et al<\/i>. Chronic anemia complicated by cardiac failure, pulmonary hypertension, and pericardial effusion: a case report. J Med Case Rep 2023; 17: 44.","DOI":"10.1186\/s13256-022-03686-z"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Galaris D, Barbouti A, Pantopoulos K. Iron homeostasis and oxidative stress: an intimate relationship. Biochim Biophys Acta Mol Cell Res 2019; 1866: 118535.","DOI":"10.1016\/j.bbamcr.2019.118535"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ren X, Johns RA, Gao WD. Right heart in pulmonary hypertension: from adaptation to failure. Pulm Circ 2019; 9: 2045894019845611.","DOI":"10.1177\/2045894019845611"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Mi\u00f1ana G, Santas E, de la Espriella R, <i>et al<\/i>. Right ventricular function and iron deficiency in acute heart failure. Eur Heart J Acute Cardiovasc Care 2021; 10: 406-14.","DOI":"10.1093\/ehjacc\/zuaa028"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood Rev 2017; 31: 225-33.","DOI":"10.1016\/j.blre.2017.02.004"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chron Dis 2018; 2018: 9394060.","DOI":"10.1155\/2018\/9394060"},{"key":"42","unstructured":"42. Shin DH, Kim HS, Park MJ, Suh IB, Shin KS. Utility of access soluble transferrin receptor (sTfR) and sTfR\/log ferritin index in diagnosing iron deficiency anemia. Ann Clin Lab Sci 2015; 45: 396-402."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wood JC. Use of magnetic resonance imaging to monitor iron overload. Hematol Oncol Clin North Am 2014; 28: 747-64.","DOI":"10.1016\/j.hoc.2014.04.002"},{"key":"44","unstructured":"44. Xanthouli P, Gordjani O, Benjamin N, <i>et al<\/i>. Reduced iron availability in CTEPH and its potential impact on clinical outcomes. Sci Rep 2021; 11: 16654."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ravingerov\u00e1 T, Kindernay L, Bartekov\u00e1 M, <i>et al<\/i>. The role of iron deficiency in pathophysiology of cardiovascular diseases. Int J Mol Sci 2020; 21: 788.","DOI":"10.3390\/ijms21217889"},{"key":"46","unstructured":"46. Surico G, Muggeo P, Muggeo V, <i>et al<\/i>. Iron overload cardiomyopathy in thalassaemia major: an Italian multicenter cardiological study in childhood. Ann Hematol 2023; 102: 185-95."}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/4\/65_24-055\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:10:46Z","timestamp":1722658246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/4\/65_24-055\/_article"}},"subtitle":["Implications, Supplementation, and Future Directions"],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-055","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"article-number":"24-055"}}